PRODUCT LITERATURE
Efficacy of L-ornithine-L-aspartate as an adjuvant therapy in cirrhotic patients with hepatic encephalopathy
Hepatic encephalopathy is characterized by the development of impaired central nervous system
function that may range from trivial abnormalities of consciousness, personality, behaviour and/or intellectual function to deep coma. Hepatic encephalopathy may be clinically invisible, i.e. minimal or sub-clinical, a syndrome that can only be detected by the demonstration of subtle
psychometric or electrophysiological abnormalities
No other version available